CNS Refresh: Boehringer's New Approach To Tricky Neuropsychiatry Diseases

 
• By Lucie Ellis-Taitt

Boehringer Ingelheim is seeking partners with early-stage, novel approaches to neuropsychiatry disorders under its strategy of applying "fresh thinking" to diseases of the central nervous system with high unmet need.

Doctor
Boehringer believes advances in CNS scientific understanding mean pharma needs a new approach • Source: Shutterstock

More from Neurological

More from Therapy Areas